Ami Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 5.40 Cr
as on 22-12-2024
- Paid Up Capital ₹ 5.40 Cr
as on 22-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -98.92%
(FY 2019)
- Profit 70.60%
(FY 2019)
- Ebitda 71.79%
(FY 2019)
- Net Worth -11.46%
(FY 2019)
- Total Assets -13.58%
(FY 2019)
About Ami Bio Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.40 Cr and a paid-up capital of Rs 5.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kiranben Chovatia and Ameeshi Chovatia serve as directors at the Company.
- CIN/LLPIN
U52100GJ2011PTC063805
- Company No.
063805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ami Bio Tech Private Limited offer?
Ami Bio Tech Private Limited offers a wide range of products and services, including Coffee Beans, Green Coffee Beans, Multivitamin Tablets & Capsules, Multivitamin Gummy, Dietary Supplements, Omega 3 Capsule, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Ami Bio Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiranben Chovatia  | Director | 27-Jan-2011 | Current |
| Ameeshi Chovatia | Director | 16-Aug-2016 | Current |
Financial Performance of Ami Bio Tech.
Ami Bio Tech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 98.92% decrease. The company also saw a substantial improvement in profitability, with a 70.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ami Bio Tech?
In 2019, Ami Bio Tech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ami Drugs And Speciality Chemicals Private LimitedActive 21 years 10 monthsKiranben Chovatia and Ameeshi Chovatia are mutual person
Ami Lifesciences Pvt LtdActive 30 years 9 monthsKiranben Chovatia and Ameeshi Chovatia are mutual person
- Adc Finserv Private LimitedActive 4 years 4 months
Kiranben Chovatia and Ameeshi Chovatia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ami Bio Tech?
Ami Bio Tech has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ami Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ami Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
